Drugs / Tongluo Kaibi Tablet
Tongluo Kaibi Tablet
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT07708948 | Jan 2024 → Oct 2025 | fibromyalgia | Guang'anmen Hospital of China Academy of Chinese Medical Sciences | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Tongluo Kaibi Tablet | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07708948 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “Tongluo Kaibi Tablet, an approved proprietary Chinese medicine with collaterals-dredging and blood-activating effects” NCT07708948 ↗ |